Pro-inflammatory cytokine changes in patients with cancer after BAL Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004
Airway fibroblasts phenotype markers after pro-inflammatory cytokines challenge Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Proinflammatory cytokines production in patients with purulent destructive lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001
Montelukast reduces Th2 type cytokines in induced sputum in mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Pro-inflammatory cytokines stimulate airway mucus secretion in a rat model of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 520s Year: 2001
Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005
Proinflammatory cytokine IL-6 detetion in severe COPD patients: Focus on roflumilast Source: International Congress 2018 – New methods for diagnosing and treating lung diseases Year: 2018
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
mRNA expression for Th2 and Th1 derived cytokines in induced sputum Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Leptin and inflammatory cytokines during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Influence of montelukast on T cell migration, production of Th2-type cytokines and proinflammatory cytokines Source: Eur Respir J 2004; 24: Suppl. 48, 129s Year: 2004
MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Characteristic of cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006
Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Inflammation and airways Year: 2009
Salivary proinflammatory cytokines and airway bacterial infection in Bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021